Queen Square Centre for Neuromuscular Diseases


LiCALS open label extension trial of lithium carbonate in amyotrophiclateral sclerosis (ALS/MND)

Further information on the original study is available.

SponsorUniversity College London Hospitals NHS Foundation Trust
FunderMotor Neurone Disease Association and NIHR
CIDr Richard Orrell
UK sitesLondon Queen square
Contact detailsr.orrell@ucl.ac.uk

This was an open label extension study for patients who had completed the lithium carbonate trial.

The objective was to obtain further evidence of the safety of lithium carbonate in doses achieving levels of 0.4-0.8 mmol/l.